Home Exercise Program for Pulmonary Hypertension

The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease

Recruiting N/A Interventional Study
Pulmonary Hypertension Interstitial Lung Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
30 (estimated)
Sponsor
University of Rochester · Other
Who this trial is looking for

This trial is looking for adults with pulmonary hypertension related to interstitial lung disease. Participants will follow a structured exercise program at home for 16 weeks and complete check-ins to see how they are doing.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am over 18 years old.
  • I have pulmonary hypertension with interstitial lung disease.
  • I have stable therapy dosing for at least 30 days.
  • I go to the University of Rochester Medical Center Pulmonary Hypertension Clinic.
  • I can access a smartphone or email.
  • I am clinically stable.

You may not be able to join if

  • I am pregnant.
  • I am in WHO Functional Class IV.
  • I cannot walk.
  • I have resting tachycardia over 120 beats per minute.
  • I lack access to email or text messaging.
  • I am participating in a rehabilitation program.
  • I have pulmonary hypertension Groups 1, 2, 4, or 5.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
This study evaluates the effects of a structured home exercise program in participants with pulmonary hypertension associated with interstitial lung disease. Participants will complete a defined exercise regimen over a 16-week period, and functional capacity and patient reported outcomes will be assessed at baseline and after the intervention. The study aims to determine whether a home-based exerc…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Follows at University of Rochester Medical Center Pulmonary Hypertension Clinic. * Adult patients (\>18 years old) with right heart catheterization confirmed pulmonary hypertension interstitial lung disease on stable therapy dosing for at least 30 days. * Access to a smart pho…
Contacts

Daniel Lachant, DO

585 273 4608

Daniel_Lachant@urmc.rochester.edu

CONTACT